Avalo Therapeutics 2025 Financial Review
Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s ...
Wednesday, August 5, 2026
Tag: Avalo
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.